Management Team

Amos Michelson, Chairman

Amos Michelson was the Chief Executive Officer of Creo Inc from June 1995, until Kodak purchased Creo in May 2005. He joined Creo in 1991 and served in positions including Vice President Business Strategy, Managing Director, and Chair of the Board of Directors until his appointment as CEO. Under Amos' leadership, Creo grew to employ over 4000 personnel and generate $650 million USD annual revenue. Prior to joining Creo, Mr. Michelson was the CEO of Opal Inc., a semi-conductor equipment company and prior to this Mr. Michelson was the Chief Operating Officer of Optrotech Ltd., a developer and manufacturer of optical and imaging systems for the electronic industry.

Mr. Michelson is a past member of the Premier's Technology Council and in 1999 was named Entrepreneur of the Year, along with Dan Gelbart, by Ernst & Young. In 2005, Mr. Michelson was named the BCTIA Person of the Year, an award presented to an individual who has made an outstanding contribution to the technology industry.

Mr. Michelson holds a Master of Business Administration from the Stanford Business School and a Bachelor of Science in electrical engineering from the Technion, Israel Institute of Technology.

Doug Goertzen, CEO

Prior to Kardium, Doug Goertzen held the position of General Manager, Proofing and Color at Eastman Kodak Company. Goertzen was responsible for the $55 million worldwide proofing and color business and managed the 130 person team developing the proofing and color product portfolio. Goertzen held senior positions in service, development and management during his 12 year tenure at Kodak and Creo Inc. (which was acquired by Kodak in 2005) and brings significant expertise in both product research and strategy to Kardium.

Doug graduated with a B.A.Sc. in Electrical Engineering from Simon Fraser University.

Dr. Sam Lichtenstein, Director

Dr. Sam Lichtenstein currently holds numerous senior medical positions including Head of the UBC Division of Cardiovascular Surgery, Head of Cardiovascular & Thoracic Surgery Division at St. Paul's Hospital, and Member of the Residency Education Committee. He was also formerly Medical Director at the BC Provincial Heart Centre.

Dr. Lichtenstein is a world renowned practitioner and researcher in cardiovascular surgery. He has made many significant contributions to heart surgery techniques during his career and has recently been featured on Fox News for performing the world's first minimally invasive ?beating heart? aortic valve replacement surgery.

Dan Gelbart, Technology Advisor

Dan Gelbart co-founded Creo, a high tech company delivering products for the printing industry, in 1984. He served as President and then Chief Technology Officer until July 2005, when Creo was sold to Kodak for $1 billion US. At the time of the sale Creo had 4000 employees and was the largest player in its field. A significant portion of Creo's award-winning technology was developed by Gelbart.

Gelbart also developed patented technology that served as the basis for two Vancouver based companies: Cymbolic Sciences, in imaging, and MDI, in telecom. Both companies experienced rapid growth and were acquired by large corporations (Schlumberger and Motorola). Dan Gelbart has over 100 US patents to his name. Cumulative revenues of the products based on these patents are in the billions of dollars to date.

Gelbart has received multiple awards, including the British Columbia Science Council Gold Medal (twice), Institute of Printing Gold Medal, Honorary Doctorate (from Simon Fraser University), and 1999 Entrepreneur of the Year, along with Amos Michelson, by Ernst & Young.

Dan holds a B.Sc. and M.Sc. in Electrical Engineering from the Technion, Israel Institute of Technology.